The objectives of the present study were to evaluate the best pharmacological measure among atorvastatin , fenofibrate and niacin aimed to raise HDL-C and its effect in decreasing the estimated Framingham-10-year CHD risk percentage ( CHD-RP ) among high risk ILHDL-C cases in north India .